He’s back for another buy, non-exec snaps up more Dr Martens shares

Dr Martens announced its independent non-executive director Robert Hanson has been continuing to purchase the brand’s stock, in what looks like a further positive sign for the global footwear retailer.

In a release to the London Stock Exchange, Dr Martens said Hanson has just purchased another 104,000 shares, worth over £80,000. This is in addition to the 96,000 shares he purchased a week ago (8 December) to the tune of around £75,000.

Hanson, who joined the Dr Martens’ board in March as a non-executive director and was previously president of Americas at Levi’s as well holding CEO roles at American Eagle Outfitters. He looks to be banking on a positive future for Doc Martens (and his post) with directorship purchases taken as a sign they’re expecting an improving performance in the markets and at retail.

Dr Martens is currently working through a recovery from a major period of weakness and it seems to be yielding results. Its first half update in November showed progress, with the America recovering.

Six-month results for the FY26 period to late September showed the execution of its new strategy on track with full-price DTC revenue rising 6%.

But there were some negative figures with overall revenue on a reported basis dipping by 0.8% to £322 million. However, it would have risen by 0.8% at constant currency rates.